CSP
22 min read
21

Pharming announces a recommended cash offer of SEK 0.45 per share to the shareholders of Abliva

December 15, 2024
0

Reading Time: 15 minutes This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited

Continue Reading
Casinoble Empowers Players with Resources for Smarter, Safer Play
CSP
3 min read
23

Casinoble Empowers Players with Resources for Smarter, Safer Play

December 15, 2024
0

Reading Time: 2 minutes Dublin, Ireland – December 15, 2024 – Casinoble, Ireland’s trusted platform for online casino reviews, is excited to announce the launch of a dedicated educational hub designed to promote safer, smarter gambling. With resources tailored specifically to Irish players, Casinoble aims to

Continue Reading
Bisleri Unviels New #DRINKITUP Sports Campaign Featuring Shahid Kapoor and Football Stars
NV
3 min read
31

Bisleri Unviels New #DRINKITUP Sports Campaign Featuring Shahid Kapoor and Football Stars

December 14, 2024
0

Reading Time: 3 minutes Bisleri International, India’s leading packaged drinking water player today unveiled its latest Bisleri #DRINKITUP sports campaign featuring Bollywood star Shahid Kapoor alongside prominent football franchises. The campaign emphasizes the importance of hydration in sports while encouraging audience to embrace the excitement of football.  

Continue Reading
Spine Doctor in Bangalore Redefines Spine Care with an Enhanced Digital Platform
NV
3 min read
30

Spine Doctor in Bangalore Redefines Spine Care with an Enhanced Digital Platform

December 14, 2024
0

Reading Time: 2 minutes Dr. Umesh Srinkantha, the most famous spine doctor in Bangalore, and the founder of Spine360, has come up with two huge achievements in spine care. The first one is the release of a new digital platform which unlike the other ones was specifically created to

Continue Reading
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell
BWI
4 min read
29

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

December 14, 2024
0

Reading Time: 3 minutes Mont-Saint-Guibert, Belgium & TOKYO, Japan:   BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and Cellistic, a leader in advanced iPS cell therapy manufacturing, today announced a process development and manufacturing

Continue Reading
TVS Motors, Reliance Jio, Tata AIG, OYO, ONGC Videsh and HPCL win 17th BML Munjal Awards for Excellence in Learning & Development
NV
4 min read
25

TVS Motors, Reliance Jio, Tata AIG, OYO, ONGC Videsh and HPCL win 17th BML Munjal Awards for Excellence in Learning & Development

December 14, 2024
0

Reading Time: 3 minutes TVS Motors, Reliance Jio, Tata AIG, OYO, ONGC Videsh and HPCL have been adjudged winners of the 17th BML Munjal Awards for Business Excellence in Learning & Development.   L-R: Shri. Sunil Kant Munjal, Chairman Hero Enterprise; Hon’ble

Continue Reading
Latteys Industries Limited Achieves Significant Milestones in 2024, Strengthening Its Leadership in Solar Submersible Pumps
NV
4 min read
26

Latteys Industries Limited Achieves Significant Milestones in 2024, Strengthening Its Leadership in Solar Submersible Pumps

December 14, 2024
0

Reading Time: 3 minutes Latteys Industries Limited, a leading NSE-listed manufacturer of energy-efficient solar submersible pumps, has reported a remarkable year in 2024. The company has received several significant orders, reinforcing its presence across India and bolstering its reputation as a committed player in India’s green energy initiatives.

Continue Reading
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
BWI
13 min read
28

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

December 14, 2024
0

Reading Time: 9 minutes Zug, Switzerland:   Ad hoc announcement pursuant to Art. 53 LR   Approximately 7% of people in the United States (U.S.) have atopic dermatitis – a common, chronic, and flaring inflammatory skin disease, characterized by persistent itch and recurrent skin lesions1-4

Continue Reading
Experian’s 2024 Global Identity & Fraud Report Spotlights Huge Growth in Highly Personalized GenAI-Driven Fraud Attacks
BWI
3 min read
27

Experian’s 2024 Global Identity & Fraud Report Spotlights Huge Growth in Highly Personalized GenAI-Driven Fraud Attacks

December 14, 2024
0

Reading Time: 3 minutes Dublin, Ireland & Costa Mesa, Calif., United States:   Today, Experian announced its 2024 Global Identity & Fraud Report that provides a comprehensive view of the consumer and business response to the latest fraud patterns and fraud‑mitigation strategies in the worldwide financial

Continue Reading
CSP
1 min read
20

#24-430 Listing of Derivatives at NGM

December 13, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading